BostonGene

About:

BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.

Website: http://www.bostongene.com/

Twitter/X: bostongenesys

Top Investors: NEC Corporation, Japan Industrial Partners, Impact Investment Capital

Description:

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies

Total Funding Amount:

$200M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2015-01-01

Hub Tags:

Unicorn

Founders:

Andrew Feinberg

Number of Employees:

251-500

Last Funding Date:

2022-04-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai